These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 27766741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of Vibrio cholerae O1 from Phage-Displayed Human Synthetic Fab Library.
    Kim D, Hong J, Choi Y, Han J, Kim S, Jo G, Yoon JY, Chae H, Yoon H, Lee C, Hong HJ.
    J Microbiol Biotechnol; 2020 Nov 28; 30(11):1760-1768. PubMed ID: 32876069
    [Abstract] [Full Text] [Related]

  • 7. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.
    Vaccine; 2009 Feb 25; 27(9):1386-92. PubMed ID: 19146897
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Peptides mimicking Vibrio cholerae O139 capsular polysaccharide elicit protective antibody response.
    Falklind-Jerkérus S, Felici F, Cavalieri C, Lo Passo C, Garufi G, Pernice I, Islam MM, Qadri F, Weintraub A.
    Microbes Infect; 2005 Dec 25; 7(15):1453-60. PubMed ID: 16046165
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S, Boutonnier A, Mulard LA, Fournier JM.
    Microbiology (Reading); 1999 Sep 25; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [Abstract] [Full Text] [Related]

  • 19. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice.
    Rollenhagen JE, Kalsy A, Cerda F, John M, Harris JB, Larocque RC, Qadri F, Calderwood SB, Taylor RK, Ryan ET.
    Infect Immun; 2006 Oct 25; 74(10):5834-9. PubMed ID: 16988262
    [Abstract] [Full Text] [Related]

  • 20. Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry.
    Dharmasena MN, Jewell DA, Taylor RK.
    J Biol Chem; 2007 Nov 16; 282(46):33805-33816. PubMed ID: 17881351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.